Hospital San Rafael

Madrid 28016

1 studies enrolling now · 8 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)

Studies at this site

• Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
• Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension — Stopped early
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• A Study for Patients Who Completed VITALITY-ALS (CY 4031) — Completed
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed